Glenmede Trust’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $999K | Buy |
20,666
+11,713
| +131% | +$566K | 0.01% | 699 |
|
|
2024
Q4 | $346K | Sell |
8,953
-6,028
| -40% | -$233K | ﹤0.01% | 1047 |
|
|
2024
Q3 | $674K | Sell |
14,981
-525
| -3% | -$23.6K | ﹤0.01% | 837 |
|
|
2024
Q2 | $537K | Buy |
15,506
+4,055
| +35% | +$141K | ﹤0.01% | 882 |
|
|
2024
Q1 | $331K | Buy |
+11,451
| New | +$331K | ﹤0.01% | 1029 |
|